© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Moxifloxacin Hydrochloride draws attention in pharmaceutical circles as a refined synthetic antibacterial chemical, celebrated for its robust activity against a range of bacterial pathogens. This compound finds wide use as a raw material in various antibiotic preparations. Structurally classified as a fluoroquinolone, its action knocks out DNA gyrase and topoisomerase IV, enzymes bacteria need to survive. Whether you’re a pharmacist, chemist, or curious about advanced drug development, understanding this molecule gives a clear sense of its value as both a laboratory compound and backbone for finished medicines.
In solid form, Moxifloxacin Hydrochloride generally presents as a yellow crystalline powder, sometimes forming small flakes or granules. This color stands out as a visual confirmation during quality checks. If you run your hands over it through gloves, it’s noticeably fine, flowing steadily—ideal for accurately measuring out raw material in pharmaceutical production. At room temperature, its melting point ranges from about 225°C to 230°C, demonstrating its stability under typical handling conditions. Solubility in water means solutions mix cleanly, but density changes in solution compared to crystal or powder are subtle; its bulk density hovers around 0.4-0.5 g/cm³ in powder form, which guides storage and blending. At high concentrations in stock solutions, Moxifloxacin Hydrochloride appears as a clear to slightly yellowish liquid. These details, small at first, become critical for anyone managing storage, transport, or compounding bulk pharmaceuticals.
Chemically, this compound’s molecular formula reads C21H24FN3O4·HCl. The hydrochloride part increases water solubility, a crucial trait for injectables and some oral drugs. Zooming in, the molecule’s structure includes a carboxylic acid group, a fluorine atom on the quinolone ring, and a methoxy substituent—features supporting its broad antimicrobial reach. Each group on the backbone changes how it behaves in manufacturing or inside the gut. The solid form’s purity sits above 99%, measured batchwise with specific analytical machines. Understanding the structure not only enhances synthesis but tightens control over product quality: a slip here triggers questions for regulators and patients alike.
Moxifloxacin Hydrochloride falls under HS Code 29419090, representing other antibiotics. Knowing this code matters for customs, international shipping, and procurement. Specifications detail assay purity (often 99.0–101.0%), loss on drying (below 0.5%), and limits for related substances. These numbers are not arbitrary; experience with global audits and batch failures shows even slight deviations can halt shipping, raise costs, or threaten patient safety. Documentation typically describes crystal habit, color, solubility in common solvents, and stability under light or heat. Pharmacopoeial standards (USP, EP, JP) often guide these specifications, so every batch should stride past those benchmarks before going anywhere near a factory or pharmacy.
Bulk Moxifloxacin Hydrochloride, stored in drums or bags lined with anti-static material, keeps its density stable under warehouse conditions. Knowing the density of both solid and solution forms impacts how much storage space to allocate, the type of measuring scoops to use, and even how to avoid fine airborne dust during transfers. Some facilities use the powder straight in weighing booths, while others reconstitute it in sterile rooms for solutions. The right humidity, temperature, and light exposure become top priorities; experience shows slipping up here can cause clumping, loss of potency, or the start of slow degradation. For those working with this compound daily, small acts like tightly resealing drums or using air filters are routine parts of the safety culture.
Handling Moxifloxacin Hydrochloride demands respect for safety. Inhaling dust, accidental skin contact, or eye exposure can irritate. Labels carry hazard codes for chemical workers, often emphasizing use of gloves, goggles, and well-ventilated spaces. Regulatory data shows it’s classified as harmful if swallowed or inhaled in bulk form, with potential for allergic reactions in sensitive workers. Long experience in controlled environments supports this: improper handling directly leads to safety incidents or product recalls. Waste disposal requires strict control; compound traces, if washed down drains, risk polluting water supplies and contributing to environmental antibiotic resistance. Working solutions must be done up with precision; even minor splashes can hurt lab workers, so routine training covers risk, emergency washing, and spill cleanup.
In manufacturing, Moxifloxacin Hydrochloride’s quality as a raw material influences the reliability of the entire antibiotic production chain. As someone who’s seen rejection of large active ingredient lots, the lesson comes home: every property, from appearance to assay value, affects batch outcome, final product release, and ultimately, patient health. Companies sourcing this compound stay close to suppliers with proven track records. Data management, traceability, and third-party audits help ensure that from API (active pharmaceutical ingredient) drum to tableted or injectable form, standards never slip. Root cause investigations over the years show that mix-ups in raw material grades create more cost, waste, and delays than almost any other error.
Best practices in handling, transporting, and storing Moxifloxacin Hydrochloride arise from lived experience and tight regulatory guidance. Purchase agreements specify test certificates with each lot, and storage remains dry, cool, with drums kept off concrete to avoid unexpected heat transfer. Many manufacturers now invest in automated weighing and powder handling systems, reducing operator exposure and improving accuracy. Barcode tracking aids inventory checks, so no drum is lost, and shelf life limits are respected. Safety training for employees covers the right gloves, lab coats, masks, and how to report spills or unknown crystals. Compliance officers run quarterly reviews, checking logs not just for regulatory boxes but for true data integrity—because in this sector, a single missed step can ripple all the way to a hospital bedside.
